Status:
COMPLETED
Pressure-Volume Loop During High-Risk PCI
Lead Sponsor:
Henry Ford Health System
Collaborating Sponsors:
Abiomed Inc.
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
This study will examine the physiologic effects on loading conditions and contractility of the left ventricle during high-risk primary coronary intervention (HRPCI) in the Cardiac Cath Lab. This will...
Detailed Description
Given the complexity of patients treated by high risk percutaneous coronary interventions (HRPCI), mechanical circulatory support (MCS) devices are increasingly used to maintain hemodynamic stability ...
Eligibility Criteria
Inclusion
- Adult patients (18 years and older) with known coronary artery disease and planned elective HRPCI procedures.
Exclusion
- Any patient not considered appropriate for elective HRPCI procedures.
Key Trial Info
Start Date :
April 19 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 12 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04681313
Start Date
April 19 2021
End Date
September 12 2024
Last Update
November 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Hospital
Detroit, Michigan, United States, 48202